The microfluidic oral diagnostic group is an international collaboration headed by Dr. Daniel Malamud and comprised of investigators from New York University College of Dentistry, the University of Pennsylvania School of Engineering and Applied Science, Leiden University Medical Center, and Lehigh University. The group is funded by the NIH NIDCR and charged with the goal of developing a handheld device that is capable of performing as a rapid point of care system for the diagnosis of infectious diseases. The group's initial focus is on the detection of multiple viral and bacterial pathogens monitoring RNA, DNA, antigen, and antibody. For proof-of-concept, the group is focusing on the multiplexed detection of HIV and S. pyogenes.